InVivo Therapeutics Holdings Co (NVIVQ)

NVIVQ Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	1	5	16	17	2	14
Market Cap Growth	-41.72%	-71.20%	-8.87%	701.01%	-84.76%	-46.70%
Enterprise Value	-7	-11	-2	-1	-3	-3
PE Ratio	-	-0.43	-1.58	-1.89	-0.18	-0.60
PB Ratio	0.13	0.29	0.86	0.89	0.38	0.87
P/FCF Ratio	-0.35	-0.42	-1.75	-1.79	-0.21	-1.14
P/OCF Ratio	-0.34	-0.43	-1.77	-1.80	-0.21	-1.14
EV/EBITDA Ratio	0.58	1.10	0.22	0.15	0.28	0.11
EV/EBIT Ratio	0.56	1.05	0.21	0.15	0.27	0.11
EV/FCF Ratio	0.51	1.02	0.23	0.14	0.31	0.20
Debt / Equity Ratio	-	0.06	0.07	0.05	0.24	0.01
Debt / EBITDA Ratio	-	-0.10	-0.14	-0.12	-0.12	0.00
Debt / FCF Ratio	-	-0.09	-0.15	-0.11	-0.13	-0.01
Quick Ratio	12.88	6.76	7.29	9.88	2.48	7.56
Current Ratio	14.30	7.27	7.33	9.97	2.55	7.77
Interest Coverage	-60.77	-68.47	-3297.33	-	-45.57	-112.70
Return on Equity (ROE)	-75.00%	-77.50%	-45.00%	-77.90%	-126.30%	-228.50%
Return on Assets (ROA)	-65.00%	-62.80%	-40.00%	-63.00%	-92.70%	-121.70%
Return on Capital (ROIC)	-110.52%	-63.79%	-50.97%	-45.02%	-166.70%	-78.76%
Earnings Yield	-811.74%	-233.10%	-63.32%	-52.91%	-552.56%	-166.68%
FCF Yield	-877.10%	-236.48%	-57.15%	-55.83%	-482.31%	-88.08%
Buyback Yield / Dilution	-123.21%	-16.08%	-379.40%	-1958.36%	-101.59%	-278.71%
Total Shareholder Return	-123.21%	-16.08%	-379.40%	-1958.36%	-101.59%	-278.71%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).